论文部分内容阅读
内镜下逆行胰胆管道影(ERCP)术后胰腺炎的发生率在1％-40％之间,预防ERCP术后胰腺炎发生的措施有操作技术方面、术前和术后药物预防和术前对病人的选择。药物预防目的是减少胰酶的分泌、阻断胰酶介导的炎性级连反应和阻断溶酶体的水解等
The incidence of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) is between 1% and 40%. The measures to prevent the occurrence of post-ERCP pancreatitis include operation technique, preoperative and postoperative drug prevention and surgery Before the patient’s choice. The purpose of drug prophylaxis is to reduce pancreatic enzyme secretion, block pancreatin-mediated inflammatory cascade reactions and block lysosomal hydrolysis